Trials / Completed
CompletedNCT03644875
Study of Etacoat in Patients With Cataract Surgery Via the Anterior Chamber
A Prospective, Single Center, Non-comparative, 90-Day Follow-up, Postmarket Clinical Investigation of Etacoat in Patients With Cataract Surgery Via the Anterior Chamber
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- Croma-Pharma GmbH · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective, single center, non-comparative, 90-day follow-up, post-market clinical investigation of etacoat in patients undergoing cataract surgery. The performance is evaluated by the preservation of endothelial cells measured by specular microscopy at the follow-up visit in comparison to baseline values.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | etacoat | Etacoat is a HPMC formulation intended to be used in ophthalmic anterior segment cataract surgery. |
Timeline
- Start date
- 2018-06-28
- Primary completion
- 2019-05-16
- Completion
- 2019-05-16
- First posted
- 2018-08-23
- Last updated
- 2024-12-10
Locations
1 site across 1 country: Austria
Source: ClinicalTrials.gov record NCT03644875. Inclusion in this directory is not an endorsement.